Live Breaking News & Updates on Greater Charlotte Advisory Committee

Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is back on track with a potential drug to treat rapid heart rates in certain cardiovascular disorders.The company in late March re-submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of etripamil for the management of paroxysmal supraventricular tachycardia (PSVT), a type of arrhythmia or abnormal heart rhythm.  ....

United States , North Carolina , Duke University , Ji Xing , Joseph Oliveto , Corie Curtis , Ji Xing Pharmaceuticals , Drug Administration , Research Triangle , Research Triangle Region , Carolina Biotechnology Center , Greater Charlotte Advisory Committee , Biotech Center , Ncbiotech Greater Charlotte Office , Duke University School Of Medicine , Milestone Pharmaceuticals , New Drug Application , North Carolina Biotechnology , Duke University School , Charlotte Based Chelsea Therapeutics , Queen City , Greater Charlotte , Pappas Ventures ,